Aug 11, 2026 08:00AM
Aug 6, 2026 08:00AM
Aug 6, 2026 08:00AM
Jul 7, 2026 08:01AM
Jul 7, 2026 08:00AM
May 5, 2026 04:30PM
Apr 17, 2026 04:05PM Theriva Biologics to present VCN-01 cancer trial data at AACR meeting
Apr 17, 2026 04:05PM
Mar 24, 2026 09:50AM
Mar 23, 2026 08:01AM
Mar 23, 2026 08:00AM
Mar 23, 2026 08:00AM
Mar 12, 2026 08:00AM
Feb 3, 2026 08:01AM Theriva Biologics to present VCN-01 retinoblastoma trial data at APAO 2026
Feb 3, 2026 08:00AM
Dec 29, 2025 08:00AM
Dec 29, 2025 08:00AM
Nov 12, 2025 08:00AM
May 27, 2025 08:01AM
May 27, 2025 08:00AM
May 7, 2025 07:00AM Theriva Biologics (TOVX) Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01
May 7, 2025 07:00AM
Mar 31, 2025 08:03AM
Mar 31, 2025 08:00AM
Mar 6, 2025 04:10PM
Dec 5, 2024 08:00AM
Dec 5, 2024 08:00AM
Nov 12, 2024 08:00AM Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results
Oct 16, 2024 08:02AM
Oct 16, 2024 08:00AM
Sep 23, 2024 08:00AM
Aug 13, 2024 08:00AM
Jul 31, 2024 08:16AM
Jul 31, 2024 08:15AM
May 23, 2024 08:15AM Theriva Biologics (TOVX) Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
May 23, 2024 08:15AM
Nov 13, 2023 08:00AM
Aug 8, 2023 08:00AM
Jun 27, 2023 04:14PM
Jun 27, 2023 04:10PM
May 11, 2023 08:00AM
Mar 30, 2023 08:00AM Theriva Biologics Reports Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results
Jan 17, 2023 08:00AM
Nov 10, 2022 04:45PM

328,607 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All